Drug information for MYAMBUTOL
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
100MG
Prescription
AB
ETHAMBUTOL HYDROCHLORIDE
Ethambutol
STI PHARMA LLC
16320
2008-11-07 Label
2008-11-03 Letter
2004-04-05 Label
2004-03-28 Letter
2003-06-10 Label
2003-02-06 Letter
2003-02-06 Letter
2003-02-06 Label
2003-02-06 Label
TABLET; ORAL
200MG
Discontinued
ETHAMBUTOL HYDROCHLORIDE
Ethambutol
STI PHARMA LLC
"
TABLET; ORAL
400MG
Prescription
AB
ETHAMBUTOL HYDROCHLORIDE
Ethambutol
STI PHARMA LLC
"
TABLET; ORAL
500MG
Discontinued
ETHAMBUTOL HYDROCHLORIDE
Ethambutol
STI PHARMA LLC
"
Drug Adverse Effects information for MYAMBUTOL
Role code
Indications
Reaction
# Reports
SS
CHOLECYSTECTOMY
CHOLELITHIASIS
4
SS
CHOLECYSTECTOMY
CYTOLYTIC HEPATITIS
4
SS
CHOLECYSTECTOMY
CYTOMEGALOVIRUS INFECTION
4
SS
CHOLECYSTECTOMY
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
4
SS
CHOLECYSTECTOMY
EOSINOPHILIA
4
SS
CHOLECYSTECTOMY
FACE OEDEMA
4
SS
CHOLECYSTECTOMY
HAEMATEMESIS
4
SS
CHOLECYSTECTOMY
HAEMOGLOBIN DECREASED
4
SS
CHOLECYSTECTOMY
ISCHAEMIC STROKE
4
SS
CHOLECYSTECTOMY
LIPASE INCREASED
4
SS
CHOLECYSTECTOMY
PROTHROMBIN TIME PROLONGED
4
SS
CHOLECYSTECTOMY
PRURITUS
4
SS
CHOLECYSTECTOMY
PULMONARY EMBOLISM
4
SS
CHOLECYSTECTOMY
RECTAL HAEMORRHAGE
4
SS
CHOLECYSTECTOMY
RENAL FAILURE
4
SS
CHOLECYSTECTOMY
SKIN LESION
4
SS
GOUT
CHOLELITHIASIS
4
SS
GOUT
CYTOLYTIC HEPATITIS
4
SS
GOUT
CYTOMEGALOVIRUS INFECTION
4
SS
GOUT
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
4
SS
GOUT
EOSINOPHILIA
4
SS
GOUT
FACE OEDEMA
4
SS
GOUT
HAEMATEMESIS
4
SS
GOUT
HAEMOGLOBIN DECREASED
4
SS
GOUT
ISCHAEMIC STROKE
4
SS
GOUT
LIPASE INCREASED
4
SS
GOUT
PROTHROMBIN TIME PROLONGED
4
SS
GOUT
PRURITUS
4
SS
GOUT
PULMONARY EMBOLISM
4
SS
GOUT
RECTAL HAEMORRHAGE
4
SS
GOUT
RENAL FAILURE
4
SS
GOUT
SKIN LESION
4
SS
LYMPH NODE TUBERCULOSIS
ERYTHEMA
5
SS
LYMPH NODE TUBERCULOSIS
EYELID OEDEMA
5
SS
LYMPH NODE TUBERCULOSIS
FLUSHING
5
SS
LYMPH NODE TUBERCULOSIS
LICHENOID KERATOSIS
5
SS
LYMPH NODE TUBERCULOSIS
PRURITUS
5
SS
LYMPH NODE TUBERCULOSIS
RASH
5
SS
LYMPH NODE TUBERCULOSIS
RASH MACULAR
5
SS
LYMPH NODE TUBERCULOSIS
SKIN EXFOLIATION
5
SS
LYMPH NODE TUBERCULOSIS
SKIN TOXICITY
5
SS
LYMPH NODE TUBERCULOSIS
URTICARIA
5
SS
PLEUROPERICARDITIS
AGITATION
4
SS
PLEUROPERICARDITIS
ARRHYTHMIA
2
SS
PLEUROPERICARDITIS
CONFUSIONAL STATE
4
SS
PLEUROPERICARDITIS
DYSKINESIA
4
SS
PLEUROPERICARDITIS
SUDDEN DEATH
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
AGITATION
16
SS
PRODUCT USED FOR UNKNOWN INDICATION
ARRHYTHMIA
8
SS
PRODUCT USED FOR UNKNOWN INDICATION
CONFUSIONAL STATE
16
SS
PRODUCT USED FOR UNKNOWN INDICATION
DYSKINESIA
16
SS
PRODUCT USED FOR UNKNOWN INDICATION
SUDDEN DEATH
8
SS
TUBERCULOSIS
CARDIAC FAILURE
4
SS
TUBERCULOUS PLEURISY
CYTOLYTIC HEPATITIS
2
SS
TUBERCULOUS PLEURISY
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
2
SS
TUBERCULOUS PLEURISY
EOSINOPHILIA
2
SS
TUBERCULOUS PLEURISY
JAUNDICE
2
SS
TUBERCULOUS PLEURISY
ORAL CANDIDIASIS
2
SS
TUBERCULOUS PLEURISY
ORAL DISORDER
2
SS
TUBERCULOUS PLEURISY
PYREXIA
2
SS
TUBERCULOUS PLEURISY
RASH
2
SS
TUBERCULOUS PLEURISY
VOMITING
2
C
DEPRESSION
CYTOLYTIC HEPATITIS
1
C
DEPRESSION
HEPATOCELLULAR INJURY
1
C
DYSLIPIDAEMIA
CYTOLYTIC HEPATITIS
2
C
HIV INFECTION
DEPRESSION
2
C
HIV INFECTION
ECZEMA
2
C
HIV INFECTION
HIDRADENITIS
1
C
HIV INFECTION
LIPODYSTROPHY ACQUIRED
2
C
HIV INFECTION
LIPOHYPERTROPHY
2
C
HIV INFECTION
PHARYNGOTONSILLITIS
2
C
HIV INFECTION
SINUSITIS
2
C
HIV INFECTION
SUICIDE ATTEMPT
2
C
KERATITIS HERPETIC
ALTERNARIA INFECTION
4
C
KERATITIS HERPETIC
CHOLESTASIS
4
C
KERATITIS HERPETIC
GRANULOMA
4
C
KERATITIS HERPETIC
HEPATIC FUNCTION ABNORMAL
4
C
KERATITIS HERPETIC
HEPATOTOXICITY
4
C
KERATITIS HERPETIC
LUNG DISORDER
4
C
KERATITIS HERPETIC
MYCOBACTERIUM KANSASII INFECTION
4
C
KERATITIS HERPETIC
SKIN LESION
4
C
KERATITIS HERPETIC
TRANSAMINASES INCREASED
4
C
MYCOBACTERIUM KANSASII INFECTION
ALTERNARIA INFECTION
3
C
MYCOBACTERIUM KANSASII INFECTION
CHOLESTASIS
3
C
MYCOBACTERIUM KANSASII INFECTION
GRANULOMA
3
C
MYCOBACTERIUM KANSASII INFECTION
HEPATIC FUNCTION ABNORMAL
3
C
MYCOBACTERIUM KANSASII INFECTION
HEPATOTOXICITY
3
C
MYCOBACTERIUM KANSASII INFECTION
LUNG DISORDER
3
C
MYCOBACTERIUM KANSASII INFECTION
MYCOBACTERIUM KANSASII INFECTION
3
C
MYCOBACTERIUM KANSASII INFECTION
SKIN LESION
3
C
MYCOBACTERIUM KANSASII INFECTION
TRANSAMINASES INCREASED
3
C
PRODUCT USED FOR UNKNOWN INDICATION
ALTERNARIA INFECTION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
CHOLESTASIS
6
C
PRODUCT USED FOR UNKNOWN INDICATION
CYTOLYTIC HEPATITIS
3
C
PRODUCT USED FOR UNKNOWN INDICATION
GRANULOMA
6
C
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC FUNCTION ABNORMAL
6
C
PRODUCT USED FOR UNKNOWN INDICATION
HEPATOTOXICITY
6
C
PRODUCT USED FOR UNKNOWN INDICATION
IMMUNE SYSTEM DISORDER
8
C
PRODUCT USED FOR UNKNOWN INDICATION
LUNG DISORDER
6
C
PRODUCT USED FOR UNKNOWN INDICATION
LYMPHADENOPATHY
8
C
PRODUCT USED FOR UNKNOWN INDICATION
MYCOBACTERIUM KANSASII INFECTION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
SKIN LESION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
TRANSAMINASES INCREASED
6
C
PRODUCT USED FOR UNKNOWN INDICATION
TUBERCULOSIS
8
C
PULMONARY TUBERCULOSIS
CYTOLYTIC HEPATITIS
1
C
PULMONARY TUBERCULOSIS
HEPATOCELLULAR INJURY
4
C
PULMONARY TUBERCULOSIS
PERIARTHRITIS
3
C
RHEUMATOID ARTHRITIS
IMMUNE SYSTEM DISORDER
2
C
RHEUMATOID ARTHRITIS
LYMPHADENOPATHY
2
C
RHEUMATOID ARTHRITIS
TUBERCULOSIS
2
Ads by Google